Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Digestion|January 1, 1989
A multicenter, randomized, double-blind study comparing a daily bedtime administration of famotidine and ranitidine in short-term treatment of active duodenal ulcerR Alcalá-Santaella, J Guardia, J Pajares, et al.
Endoscopy|September 1, 1984
Heterotopic gastric mucosa in the rectumD Castellanos, P Menchen, M López de la Riva, et al.
Hepato-Gastroenterology|June 1, 1989
A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcerR Alcalá Santaella, J Guardia, J Pajares, et al.
The British Journal of Dermatology|September 23, 2014
Mohs micrographic surgery in dermatofibrosarcoma protuberans allows tumour clearance with smaller margins and greater preservation of healthy tissue compared with conventional surgery: a study of 74 primary casesC Serra-Guillén, B Llombart, E Nagore, et al.
Alimentary Pharmacology & Therapeutics|February 1, 1989
A multicentre, randomized, double-blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulcerationR Alcalá Santaella, J Guardia, J Pajares, et al.
Revista Espanola De Las Enfermedades Del Aparato Digestivo|June 1, 1989
[Course of cellular immunity in patients with chronic inflammatory intestinal disease]J L Velo Bellver, C Martínez Prieto, J Sebastián Domingo, et al.
Brain Stimulation|January 13, 2018
Similar clinical improvement and maintenance after rTMS at 5 Hz using a simple vs. complex protocol in Alzheimer's diseaseR Alcalá-Lozano, E Morelos-Santana, J F Cortés-Sotres, et al.
The Journal of Organic Chemistry|December 26, 2001
Tetrathiafulvalene derivatives as NLO-phores: synthesis, electrochemistry, Raman spectroscopy, theoretical calculations, and NLO properties of novel TTF-derived donor-pi-acceptor dyadsM González, J L Segura, C Seoane, et al.
Actas Dermo-Sifiliograficas|December 7, 2025
Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort StudyM Mansilla-Polo, M Pons-Benavent, P Fernández-Crehuet, et al.
Pageof 2